Article

Adherence Status and Influencing Factors of Acute and Preventive pharmacotherapy Among Migraine Patients in China

2025-08-22

Abstract excerpt

<title>Abstract</title> <p><bold>Objective:</bold> To investigate the current adherence status and associated factors for acute and preventive pharmacotherapy among migraine patients in China . <bold>Methods:</bold> Utilizing a prospective cohort design with retrospective identification, migraine patients first attending the Headache Clinic (Chinese PLA General Hospital, May–November 2024) were prospectively asse...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cc0e66ba-21dc-593e-a60c-cbdd071b4389
DOI: 10.21203/rs.3.rs-7366539/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Adherence Status and Influencing Factors of Acute and Preventive pharmacotherapy Among Migraine Patients in ChinaDOI 10.21203/rs.3.rs-7366539/v1Read

Real-world Treatment and Associated Healthcare Resource Use Among Migraine Patients in GermanySemantic proximity Read

A Descriptive Review of Medication Overuse Headache - from Pathophysiology to the ClinicSemantic proximity Read

A Descriptive Review of Medication Overuse HEADACHE-from Pathophysiology to the ClinicSemantic proximity Read

Migraine in men – differences in phenotype and treatment patterns: Results from the Migraine in Poland cross-sectional national surveySemantic proximity Read

Association Between Traditional Chinese Medicine and Medication Adherence in Hypertensive Patients in Mainland China: A Real-World Population-Based Cohort StudySemantic proximity Read

Epidemiological, clinical characterization and treatment patterns of migraine patients in a Colombian cohort from 2018 to 2022.Semantic proximity Read

Failure of Preventive Treatments in Migraine: An Observational Retrospective Study in a Tertiary Headache CenterSemantic proximity Read

Real-world clinical results of CGRP monoclonal antibody treatment for medication overuse headache of migraine without abrupt drug discontinuation and no hospitalizationSemantic proximity Read

Predictors of galcanezumab response in a real-world study of Korean patients with migraineSemantic proximity Read

Fremanezumab in the Prevention of High-Frequency Episodic and Chronic Migraine: A 12-Week, Multicenter, Real-Life, Cohort Study (The FRIEND Study).Semantic proximity Read

Onabotulinumtoxin A improves psychological aspects in chronic migraine patientsSemantic proximity Read

Main Clinical Characteristics of Medication Overuse HeadacheSemantic proximity Read